The Patent Finder

Annexin Pharmaceuticals AB

Also on record
Records under this name other than the patents Annexin Pharmaceuticals AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 3 of 3 · Back to Annexin Pharmaceuticals AB

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,901,614Methods for treating restenosis using annexin A5
Lapsed on the fee record
Ended Feb 27, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 27, 2026USPTO record
US 9,682,122Compounds and methods for the treatment of vascular disease
Lapsed on the fee record
Ended Jun 20, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 20, 2025USPTO record
US 9,649,355Compounds and methods for the treatment of vascular disease
Lapsed on the fee record
Ended May 16, 2025 · USPTO record
Lapsed on the fee recordEnded May 16, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited